Key Highlights

  • Fevertree Drinks plc (LSE:FEVR) shares closed at 943.5p on 3 November 2026, well above the roughly 775p level seen after interim results in September.
  • First-half Brand Revenue rose 8% at constant currency to £183.6 million, with US revenue up 11%.
  • Adjusted EBITDA increased 9% to £20.1 million, with Margin improving to 10.9%, and full-year guidance was maintained.
  • A new £60 million share buyback is under way, with purchases continuing into November and shares being cancelled.
  • Management expects a circa 60% uplift in EBITDA over the next two years, underpinned by a US profit guarantee from its partner Molson Coors.

Fevertree Drinks plc (LSE:FEVR), the world's leading supplier of premium carbonated mixers and one of the best-known companies on the FTSE AIM All-Share, is attracting strong investor attention on 4 November 2026. After an initially cool reaction to interim results in September, the shares have staged a powerful recovery, supported by steady buyback purchases, evidence of accelerating US sales and growing confidence in a multi-year profit recovery.

Why Fevertree Is in Focus Today

The share price momentum is the headline. LSE:FEVR closed at 943.5p on 3 November, more than 20% above the level reached in the immediate aftermath of interim results, when the stock fell about 5% despite beating first-half profit forecasts. The rally has been driven by a combination of daily buyback activity, director buying and data showing improving US off-trade sales.

The company has been buying back shares almost every week under its new £60 million programme. In the last week of October alone, it repurchased more than 175,000 shares at prices between about 911p and 946p, all of which will be cancelled. This follows the completion of a £100 million programme in 2025, underlining management's confidence in the value of the shares.

Interim Results Recap

For the six months to 30 June 2026, Fever-Tree brand revenue rose 8% at constant currency to £183.6 million, with growth in every major region. The US was up 11%, Europe up 10%, the UK returned to growth with a 3% rise helped by a successful Marketing campaign and warm summer weather, and the Rest of World grew 5%. Products beyond tonic now represent almost half of group revenue, showing the success of ginger beer, sodas and other mixers.

Adjusted EBITDA rose 9% to £20.1 million, and the margin improved 20 basis points to 10.9%. Diluted Earnings per Share rose 38% to 9.44p, and the Interim Dividend increased 2% to 6.09p. Full-year guidance was unchanged.

The US Partnership With Molson Coors

The most important long-term driver for Fevertree Drinks plc (LSE:FEVR) is its US partnership with Molson Coors, which took a minority stake in the Business and now handles US production, distribution and sales under a royalty-style model. In the first half, US revenue reached £66.9 million. However, the segment's EBITDA margin narrowed to 6.2% from 8.1% because of heavier marketing investment, which was the main reason shares initially fell on results day.

Management stressed that this pressure is temporary. US profits are protected by guaranteed minimum profits from Molson Coors between 2026 and 2030, and onshoring production into US facilities should cut freight and Tariff costs. Tariff rebates are expected to land in the second half. US off-trade sales momentum has built through the year, with quarterly growth rates rising from around 6% to the mid-teens.

A Path to 60% EBITDA Growth

Perhaps the most striking guidance is the expectation of a roughly 60% uplift in EBITDA over the next two years. This would be driven by US margin step-ups from onshoring, normalised marketing spend funded by Molson Coors, central cost Leverage and continued growth in Europe. Cash generation is also expected to rise faster than EBITDA, as US Working Capital is funded by the partner. Packaging costs are largely hedged for energy impacts through 2028, reducing input cost risk.

Leadership and Insider Confidence

Co-founder Tim Warrillow continues to lead the business, and Fevertree is frequently highlighted among British founder-led stocks. Insider Domenico De Lorenzo bought shares in September, adding to signs of internal confidence.

Risks to Consider

The shares trade on a premium valuation, with an EV to EBITDA multiple near 28 times, so delivery against the profit uplift plan is essential. Risks include weaker consumer spending on premium drinks, a shift in alcohol consumption trends, US tariff changes and the execution of production onshoring. Some Brokers maintain hold ratings with targets below the current share price, suggesting part of the recovery may already be priced in.

What Investors Are Watching Next

The next major update for Fevertree Drinks plc (LSE:FEVR) is typically a year-end trading statement in January, followed by full-year 2026 results in March 2027. Investors will watch for second-half US revenue acceleration, the size of tariff rebates, progress on onshoring, UK trading over the festive season, and FY27 guidance consistent with the planned EBITDA uplift.

Buyback progress and any broker upgrades will also influence near-term momentum on the FTSE AIM All-Share. A strong Christmas trading period in the UK and Europe could add further support.

Bottom Line

Fevertree Drinks plc (LSE:FEVR) has turned a lukewarm results-day reaction into a strong autumn rally. Steady buybacks, accelerating US sales and a clear plan for significant profit growth have restored investor confidence, keeping LSE:FEVR firmly in focus heading into the year-end trading update.